NCT07011199View on ClinicalTrials.gov

Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 17, 2025

Primary Completion Date

April 17, 2026

Study Completion Date

April 17, 2026

Conditions
Biliary AtresiaKasai PortoenterostomyMesenchymal Stem Cell TransplantationLiver Function DisordersLiver FibrosisSurvival Rate
Interventions
BIOLOGICAL

Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)

Intraoperative trans-portal vein injection of 20 million mesenchymal stem cells derived from umbilical cord tissue, suspended in 5 mL autologous plasma.

PROCEDURE

Kasai Portoenterostomy

Surgical procedure to create a portoenterostomy for biliary drainage in infants with biliary atresia.

Trial Locations (1)

50244

Dr. Kariadi General Hospital Medical Center, Semarang

All Listed Sponsors
lead

Universitas Diponegoro

OTHER